US Widens Probe Into Eli Lilly's FCPA Compliance

By Elaine Meyer

Law360, New York (February 23, 2010, 6:46 PM ET) -- The U.S. Department of Justice and the U.S. Securities and Exchange Commission have widened an investigation into Eli Lilly & Co. subsidiaries' compliance with a federal law that prohibits bribery of foreign officials, the company has disclosed.

In an SEC filing Monday, Lilly said it had been subpoenaed by the SEC and that both agencies had asked Lilly to voluntarily provide information related to the activities of subsidiaries in “a number of other countries,” as part of a U.S. Foreign Corrupt Practices Act investigation.

Lilly did...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles